Skip to main content
Full access
Bibliography
Published Online: 27 April 2018

Bibliography: Biomarkers in Psychiatry

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Articles from the bibliography that are reprinted in this issue are in bold type.

2017

Banerjee SB, Morrison FG, Ressler KJ: Genetic approaches for the study of PTSD: advances and challenges. Neurosci Lett 2017; 649:139–146
Bousman CA, Forbes M, Jayaram M, et al: Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools. BMC Psychiatry 2017; 17:60
Colvonen PJ, Glassman LH, Crocker LD, et al: Pretreatment biomarkers predicting PTSD psychotherapy outcomes: a systematic review. Neurosci Biobehav Rev 2017; 75:140–156
Gadad BS, Jha MK, Czysz A, et al: Biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks. J Affect Disord. 2017 Jul 5. pii: S0165-0327(17)30671-7
Li D, Karnath HO, Xu X: Candidate biomarkers in children with autism spectrum disorder: a review of MRI Studies. Neurosci Bull 2017; 33:219–237
Maron E, Nutt D: Biological markers of generalized anxiety disorder. Dialogues Clin Neurosci 2017; 19:147–158
Meeter LH, Kaat LD, Rohrer JD, et al: Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol 2017; 13:406–419
O’Bryant SE, Mielke MM, Rissman RA, et al: Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2017; 13:45–58
Strawbridge R, Young AH, Cleare AJ: Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat 2017; 13:1245–1262
Uddin LQ, Dajani DR, Voorhies W, et al: Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. Transl Psychiatry 2017; 7:e1218

2016

Bandelow B, Baldwin D, Abelli M, et al: Biological markers for anxiety disorders, OCD and PTSD—a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry 2016; 17:321–365
Cannon TD, Yu C, Addington J, et al: An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry 2016; 173:980–988
Clementz BA, Sweeney JA, Hamm JP, et al: Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 2016; 173:373–384
Fernandes BS, Steiner J, Bernstein HG, et al: C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 2016; 21:554–564
Goldsmith DR, Rapaport MH, Miller BJ: A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016; 21:1696–1709
Llorens F, Schmitz M, Ferrer I, et al: CSF biomarkers in neurodegenerative and vascular dementias. Prog Neurobiol 2016; 138-140:36–53
Muller CL, Anacker AMJ, Veenstra-VanderWeele J: The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 2016; 321:24–41
Oedegaard KJ, Alda M, Anand A, et al: The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry 2016; 16:129
Pierce K, Marinero S, Hazin R, et al: Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism spectrum disorder subtype associated with increased symptom severity. Biol Psychiatry 2016; 79:657–666
Teixeira AL, Salem H, Frey BN, et al: Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn 2016; 16:1209–1220
van Erp TG, Hibar DP, Rasmussen JM, et al: Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016; 21:547–553
Varcin KJ, Nelson CA 3rd: A developmental neuroscience approach to the search for biomarkers in autism spectrum disorder. Curr Opin Neurol 2016; 29:123–129

2015

Michopoulos V, Norrholm SD, Jovanovic T: Diagnostic biomarkers for posttraumatic stress disorder: promising horizons from translational neuroscience research. Biol Psychiatry 2015; 78:344–353

Further Reading

Cavedo E, Lista S, Khachaturian Z, et al: The Road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. J Prev Alzheimers Dis 2014; 1:181–202
Goldani AAS, Downs SR, Widjaja F, et al: Biomarkers in autism. Front Psychiatry 2014; 5:100
Jones W, Klin A: Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism. Nature 2013; 504:427–431
Lo RY, Hubbard AE, Shaw LM, et al: Alzheimer’s Disease Neuroimaging Initiative: Longitudinal change of biomarkers in cognitive decline. Arch Neurol 2011; 68:1257–1266
Risacher SL, Saykin AJ: Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol 2013; 33:386–416
Ruggeri B, Sarkans U, Schumann G, et al: Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 2014; 231:1201–1216
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421–427
Schmidt HD, Shelton RC, Duman RS: Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011; 36:2375–2394
Tamminga CA, Ivleva EI, Keshavan MS, et al: Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013; 170:1263–1274
Toledo JB, Xie SX, Trojanowski JQ, et al: Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol 2013; 126:659–670
Yehuda R, Neylan TC, Flory JD, et al: The use of biomarkers in the military: from theory to practice. Psychoneuroendocrinology 2013; 38:1912–1922

Information & Authors

Information

Published In

History

Published in print: Spring 2018
Published online: 27 April 2018

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share